Debashis Das, MD MBA’s Post

Exciting news for all people with T1D in the UK. NHS to offer people with type 1 diabetes an artificial pancreas (Hybrid Closed Loop System). It is just the beginning, hope to see soon this will be rolled out in other parts of the world. A world-first trial on the NHS showed the artificial pancreas was more effective at managing diabetes than current devices and required far less input from patients. Final draft guidance from the National Institute for Health and Care Excellence (Nice) recommends that people in England and Wales should benefit from the wearable device if their diabetes is not adequately controlled by their current pump or glucose monitor. “Using hybrid closed-loop systems will be a gamechanger for people with type 1 diabetes. By ensuring their blood glucose levels are within the recommended range, people are less likely to have complications such as disabling hypoglycaemia, strokes and heart attacks which will eventually be more cost effective in long term. “Today’s announcement makes Great Britain the first country in the world to make hybrid closed-loop widely available, as England and Wales follow the lead of Scotland, who approved the use of HCL earlier in 2022.” #t1d #insulin #diabetescare #diabetesmanagement #artificialintelligenceinhealthcare #type1diabetes #type1 #closedloop #mohfw #goi #pmoindia #icmr Suba SanthanamManjiri VermaSimon AmiesNeetal SavantMichael ChauDarren Barlow